SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001048462-14-000008
Filing Date
2014-02-14
Accepted
2014-02-14 09:57:14
Documents
1
Group Members
CHARLES E. DAVIDSONJOSEPH M. JACOBSWEXFORD FOCUSED INVESTORS LLCWEXFORD GP LLCWEXFORD SELECT EQUITIES LLCWEXFORD SPECTRUM INVESTORS LLC

Document Format Files

Seq Description Document Type Size
1 WEXFORD CAPITAL SC13G A! 02-14-14 formsc13ga1.htm SC 13G/A 208613
  Complete submission text file 0001048462-14-000008.txt   210706
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Subject) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-52909 | Film No.: 14611699
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 411 W PUTNAM AVENUE GREENWICH CT 06830
Business Address 411 W PUTNAM AVENUE GREENWICH CT 06830 2038627000
WEXFORD CAPITAL LP (Filed by) CIK: 0001048462 (see all company filings)

IRS No.: 061442624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A